StockData

VitaSpring Biomedical Co. Ltd. (VSBC) stock

VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 17, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $6.58MP/E –Yield –

What VitaSpring Biomedical keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-2861.9%vs -2.60%

How hard the assets work

Revenue per dollar of assets0.00vs 0.84

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $13.37K.

Cash and short-term investments$13.37K
EBITDA, trailing twelve months-$454.86K

Leverage and liquidity

Current ratio0.01vs 1.35
Quick ratio0.01vs 0.73

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

VSBCS&P 500
PeriodVSBCS&P 500DifferenceVSBC per yearS&P 500 per year
1 month+186.5%+0.6%+185.9 pts
3 months+186.5%+3.4%+183.1 pts
Year to date-96.8%+13.3%−110.1 pts
1 year-96.8%+16.6%−113.4 pts
3 years-99.8%+86.4%−186.2 pts-87.4%+23.1%
5 years-99.8%+81.9%−181.6 pts-71.0%+12.7%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Jul 31, 2023.

0M VSBC shares were sold short on Jul 31, 2023, up 0.0% from the previous report. At recent volumes it would take 1000.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Jul 31, 2023500.0%01000.0
Jul 14, 2023500.0%01000.0
Jun 30, 2023500.0%01000.0
Jun 15, 2023500.0%1091.0
May 31, 2023500.0%95.6
May 15, 202350-50.0%1361.0
Apr 28, 20231000.0%01000.0
Apr 14, 20231000.0%01000.0
Mar 31, 20231000.0%7471.0
Mar 15, 20231000.0%1641.0
Feb 28, 20231000.0%01000.0
Feb 15, 2023100+51.5%2301.0

Every measure, in full

25 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jul 31, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
0.00%
1.10%
Shares Change (QoQ)
0.00%
0.00%
Float
207M
27M
Shares Held by Insiders
0.00%
4.85%

Returns on capitalIndustry

Return on Assets (ROA)
-2861.9%
-2.60%

Financial positionIndustry

Current Ratio
0.01
1.35
Quick Ratio
0.01
0.73

EfficiencyIndustry

Asset Turnover
0.00
0.84

Income statement (TTM)Industry

Revenue
$0
$23.60M
Operating Income
-$454.86K
-$48.83K
Pretax Income
-$448.86K
$122.49K
Net Income
-$455.64K
-$62.45K
EBITDA
-$454.86K
-$25.17K
EPS (Diluted)
$0.00
$0.00

Balance sheetIndustry

Net Cash (Debt)
$13.37K
$15.49K
Net Cash Per Share
$0.00
$0.00
Equity (Book Value)
-$4.66M
$12.47M
Book Value Per Share
-$0.02
$0.69
Tangible Book Value
-$4.66M
$7.70K
Working Capital
-$2.25M
$3.69M

Cash flow (TTM)Industry

Operating Cash Flow
$10.57K
$41.37K

Taxes and interestIndustry

Income Tax
$6.79K
$1.35M

Scores and fair valueIndustry

Piotroski F-Score
4
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?